Joanna S.
- Country
- Poland
- Department
- NA
Research Overview
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
- Efficacy and Safety Evaluation of SAR444656 in Adults with Moderate to Severe Atopic Dermatitis: A Multinational, Double-Blind, Placebo-Controlled Phase 2 Study
- Evaluation of Subcutaneous Methotrexate Efficacy and Safety Compared to Placebo in Adults with Moderate to Severe Atopic Dermatitis
Data & Insights
Has run more than one trial at 62 of 228 partner sites.
Specializations
Dermatological Research
The investigator specializes in atopic dermatitis treatment and management, with particular focus on moderate to severe cases. Their research encompasses both established and innovative therapeutic approaches for this chronic skin condition.
- Conventional Treatment Evaluation
- Novel Biologic Therapies
- Long-term Disease Management
Therapeutic Innovation
Their research portfolio includes investigations into various therapeutic agents, including methotrexate administration and novel compounds like amlitelimab and rezpegaldesleukin for dermatological applications.
- Immunomodulatory Treatments
- Subcutaneous Drug Delivery
- Advanced Biological Therapies
Clinical Assessment
The investigator employs sophisticated clinical evaluation methods, particularly utilizing the Eczema Area and Severity Index (EASI) to assess treatment efficacy and disease progression in dermatological conditions.
- Disease Severity Measurement
- Treatment Response Evaluation
- Long-term Safety Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.